XML 65 R44.htm IDEA: XBRL DOCUMENT v3.25.0.1

OPTIONS AND AWARDS (Tables)

12 Months Ended

Dec. 31, 2024

Share-Based Payment Arrangement [Abstract]

Schedule of Assumptions for Stock Options Granted

The Company granted 704, 1,008 and 581 stock options during the years ended December 31, 2024, 2023 and 2022, respectively. The Company used the following assumptions for stock options granted during the years ended December 31, 2024, 2023 and 2022:

Grant Year						Options Granted						Weighted Average Risk-Free Rate						Expected Life						Weighted Average Volatility						Weighted Average Dividend Yield
2024						704						4.3%						6.2 years						40.5%						0.2%
2023						1,008						4.3%						6.2 years						41.3%						0.2%
2022						581						2.8%						6.2 years						42.1%						0.3%

Schedule of Exercise Price and Fair Value Displayed at Grant Date for Stock Option Grants

For the years ended December 31, 2024, 2023 and 2022, the following represents the exercise price and fair value displayed at grant date for stock option grants:

Grant Year						Granted						Weighted Average Exercise Price						Weighted Average Fair Value of Options
2024						704						$	132.46					$	60.37
2023						1,008						$	95.05					$	43.85
2022						581						$	85.74					$	37.83

Schedule of Employee Stock Option Roll Forward

The following table represents the employee stock option activity during the years ended December 31, 2024, 2023 and 2022:

			Number of Options Outstanding						Weighted Average Exercise Price						Number of Options Vested						Weighted Average Exercise Price of Options Vested
January 1, 2022			4,038						$	36.60					2,183						$	21.02
Granted			581						85.74
Forfeited			(98)						59.52
Exercised			(688)						18.43
December 31, 2022			3,833						$	46.72					2,069						$	28.87
Granted			1,008						95.05
Forfeited			(91)						71.44
Exercised			(759)						24.21
December 31. 2023			3,991						$	62.65					1,887						$	39.58
Granted			704						132.46
Forfeited			(76)						86.92
Exercised			(632)						35.28
December 31, 2024			3,987						$	78.84					1,895						$	52.64

Stock Options Outstanding, Vested and Related Details

The following table represents the employee stock option activity during the year ended December 31, 2024:

						Stock Options Outstanding																														Stock Options Vested
																																													Number Outstanding						Black-Scholes Fair Value						Remaining Contractual Life (Years)						Vested and Exercisable
Year of Grant						Exercise Price
2015						$18.20			-			$21.39						69						$	537					1						69
2016						15.93			-			16.86						112						667						2						112
2017						15.80			-			19.41						148						867						3						148
2018						22.49			-			32.71						241						2,557						4						241
2019						41.07			-			45.76						417						6,557						5						417
2020						44.84			-			59.49						406						8,020						6						301
2021						73.47			-			83.64						458						15,041						7						251
2022						79.79			-			94.88						489						18,601						8						176
2023						89.83			-			98.83						951						41,753						9						180
2024						$119.19			-			$146.37						696						42,024						10						—
TOTAL																		3,987						$	136,624											1,895

Schedule of Aggregate Intrinsic Value of Options

The aggregate intrinsic value of options outstanding, vested and expected to vest as of December 31, 2024, 2023 and 2022 is as follows:

						December 31,
Options						2024						2023						2022
Outstanding						$	219,309					$	197,819					$	183,593
Vested						152,011						137,048						136,000
Expected to vest						63,243						56,759						43,232

Schedule of Nonvested Restricted Stock Awards

A summary of the status of the Company's non-vested restricted stock awards as of December 31, 2024 and changes during the years ended December 31, 2024, 2023 and 2022 is presented below:

			Non-Vested Restricted Awards						Weighted Average Grant Date Fair Value
Nonvested at January 1, 2022			549						$	52.16
Granted			233						81.57
Vested			(269)						54.06
Forfeited			(26)						57.29
Nonvested at December 31, 2022			487						$	64.92
Granted			219						92.04
Vested			(255)						64.21
Forfeited			(20)						71.53
Nonvested at December 31, 2023			431						$	78.91
Granted			232						131.26
Vested			(215)						86.97
Forfeited			(13)						83.12
Nonvested at December 31, 2024			435						$	102.71

Schedule of Stock-Based Compensation Expense

Stock-based compensation expense recognized for the Company's equity incentive plans and long-term incentive plan for the years ended December 31, 2024, 2023 and 2022 was as follows:

									Year Ended December 31,
															2024						2023						2022
Stock-based compensation expense related to stock options															$	22,439					$	17,221					$	11,361
Stock-based compensation expense related to restricted stock awards															11,662						11,845						9,920
Stock-based compensation expense related to restricted stock awards to non-employee directors															2,082						1,688						1,439
TOTAL															$	36,183					$	30,754					$	22,720

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the change in common stock outstanding.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the changes in outstanding nonvested restricted stock units.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (f)(2)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the weighted-average grant-date fair value of equity options or other equity instruments granted during the year.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for exercisable or convertible options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (e)(2)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration